Research and Development

CSL's world-class R&D organization continues to evolve into a leading biotechnology company by advancing high-quality science and technology developed by our own world-class scientists and innovative collaborations. The R&D department uses its expertise in our strategic platforms - plasma fractionation, recombinant protein technology, cell and gene therapy and vaccine technology. This enables CSL to develop and deliver innovative medicines and vaccines that address unmet medical needs, help prevent infectious diseases and protect public health, and enable patients to lead fulfilling lives.